Gait, Hemiplegic, Stroke
Conditions
Keywords
stroke, validity, gait
Brief summary
The aim of this study is to validate the G-walk for several gait parameters, tested against a gold standard three dimensional camera system. This research will inform researchers and practitioners as to whether the G-Walk is a suitable and valid tool to easily assess walking ability in people with chronic stroke.
Detailed description
Twenty chronic stroke survivors will be recruited for this study from an independent neuro-physiotherapy practice and community exercise programme.Gait analysis will be used to look at several gait parameters through the use of a three-dimensional visual analysis system based in our Biomechanics Lab at the University of Winchester. Participants will attend testing one testing session of approximately 1 hour. During this testing session functional measures and walking trials will be assessed. Participants will first be asked to complete a set of simple movements that will contribute towards Fugl Meyer questionnaire. Twenty eight reflective markers will then be attached to specified joints and segments of the body, such as the thigh, with double sided sticky tape to allow for data collection through the camera system to collect kinematic data. The belt mounted accelerometer (G-Walk) will be positioned around the waist over the L5 vertebrae. Participants will be asked to perform 6 walking trials of 10m to collect 3D kinematic and accelerometer gait data.
Interventions
DEVICEGwalk accelerometer walking trials
No intervention. Participants will wear a belt mounted accelerometer and complete walking trials to assess validity of the device
Sponsors
University of Winchester
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* \<3 months post stroke * Lower limb impairment * Able to stand and step independently * Functional ambulation classifications (FAC) of 2-5 * Modified Rankin Scale (MRS) of 1-3 * Cognitively aware to undertake the testing session
Exclusion criteria
* Unresolved deep vein thrombosis * unstable cardiovascular conditions * open wounds * active drug resistant infection * recent fractures of involved limb * peripheral arterial disease * incontinence * severe osteoporosis * non-weight bearing.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Speed | 60 minutes | How quickly a participant walks overground |
| Cadence | 60 minutes | Steps taken per minute |
| Stride Length | 60 minutes | The distance between strides |
| Swing phase duration | 60 minutes | Percentage of the gait cycle spent in swing phase |
| Stance phase duration | 60 minutes | Percentage of the gait cycle spent in stance phase |
| Gait cycle duration | 60 minutes | The time it takes to complete one gait cycle |
| Double support duration | 60 minutes | Percentage of the gait cycle spend with both feet on the ground (double support) |
Countries
United Kingdom
Outcome results
None listed